Exosome-transmitted miR-567 reverses trastuzumab resistance by inhibiting ATG5 in breast cancer

Han, ML; Hu, JG; Lu, PW; Cao, H; Yu, C; Li, XK; Qian, XK; Yang, X; Yang, YQ; Han, N; Dou, DW; Zhang, F; Ye, ML; Yang, CC; Gu, YT; Dong, HY

Gu, YT (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Dept Breast Surg, Zhengzhou 450052, Peoples R China.; Dong, HY (corresponding author), Hainan Med Univ, Hainan Gen Hosp, Dept Gen Surg, Hainan Affiliated Hosp, Haikou 570311, Hainan, Peoples R China.

CELL DEATH & DISEASE, 2020; 11 (1):

Abstract

Trastuzumab is commonly used in the treatment of human epidermal growth factor receptor-2 positive (HER-2+) breast cancer, but its efficacy is often l......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索